14 December 2023
Day 1 - Morning
14 December 2023
Group 1B: HER2-low, HER2-0, & HR+ Breast Cancer; Clinical Trials Sold Out
14 December 2023
Group 1D: Brain Metastasis; Novel Targets
14 December 2023
Group 1E: ER+ Breast Cancer; Younger Populations; Quality of Life
14 December 2023
Group 1F: HER2+ Breast Cancer; Triple Positive Breast Cancer; Clinical Trials; Treatment Resistance Sold Out
No event found!